Literature DB >> 11704930

A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel.

H Lahat1, E Pras, T Olender, N Avidan, E Ben-Asher, O Man, E Levy-Nissenbaum, A Khoury, A Lorber, B Goldman, D Lancet, M Eldar.   

Abstract

Catecholamine-induced polymorphic ventricular tachycardia (PVT) is characterized by episodes of syncope, seizures, or sudden death, in response to physical activity or emotional stress. Two modes of inheritance have been described: autosomal dominant and autosomal recessive. Mutations in the ryanodine receptor 2 gene (RYR2), which encodes a cardiac sarcoplasmic reticulum (SR) Ca(2+)-release channel, were recently shown to cause the autosomal dominant form of the disease. In the present report, we describe a missense mutation in a highly conserved region of the calsequestrin 2 gene (CASQ2) as the potential cause of the autosomal recessive form. The CASQ2 protein serves as the major Ca(2+) reservoir within the SR of cardiac myocytes and is part of a protein complex that contains the ryanodine receptor. The mutation, which is in full segregation in seven Bedouin families affected by the disorder, converts a negatively charged aspartic acid into a positively charged histidine, in a highly negatively charged domain, and is likely to exert its deleterious effect by disrupting Ca(2+) binding.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11704930      PMCID: PMC1235548          DOI: 10.1086/324565

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  23 in total

Review 1.  Progress in the understanding of cardiac early afterdepolarizations and torsades de pointes: time to revise current concepts.

Authors:  P G Volders; M A Vos; B Szabo; K R Sipido; S H de Groot; A P Gorgels; H J Wellens; R Lazzara
Journal:  Cardiovasc Res       Date:  2000-06       Impact factor: 10.787

2.  Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2).

Authors:  N Tiso; D A Stephan; A Nava; A Bagattin; J M Devaney; F Stanchi; G Larderet; B Brahmbhatt; K Brown; B Bauce; M Muriago; C Basso; G Thiene; G A Danieli; A Rampazzo
Journal:  Hum Mol Genet       Date:  2001-02-01       Impact factor: 6.150

3.  Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia.

Authors:  P J Laitinen; K M Brown; K Piippo; H Swan; J M Devaney; B Brahmbhatt; E A Donarum; M Marino; N Tiso; M Viitasalo; L Toivonen; D A Stephan; K Kontula
Journal:  Circulation       Date:  2001-01-30       Impact factor: 29.690

4.  Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia.

Authors:  S G Priori; C Napolitano; N Tiso; M Memmi; G Vignati; R Bloise; V Sorrentino; G A Danieli
Journal:  Circulation       Date:  2001-01-16       Impact factor: 29.690

5.  Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21.

Authors:  H Lahat; M Eldar; E Levy-Nissenbaum; T Bahan; E Friedman; A Khoury; A Lorber; D L Kastner; B Goldman; E Pras
Journal:  Circulation       Date:  2001-06-12       Impact factor: 29.690

Review 6.  Intracellular calcium homeostasis.

Authors:  E Carafoli
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

7.  Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts.

Authors:  H Swan; K Piippo; M Viitasalo; P Heikkilä; T Paavonen; K Kainulainen; J Kere; P Keto; K Kontula; L Toivonen
Journal:  J Am Coll Cardiol       Date:  1999-12       Impact factor: 24.094

Review 8.  Calcium transport across the sarcoplasmic reticulum: structure and function of Ca2+-ATPase and the ryanodine receptor.

Authors:  D L Stokes; T Wagenknecht
Journal:  Eur J Biochem       Date:  2000-09

Review 9.  Catecholamine cardiotoxicity.

Authors:  G Rona
Journal:  J Mol Cell Cardiol       Date:  1985-04       Impact factor: 5.000

Review 10.  Polymorphic ventricular tachyarrhythmias in the absence of organic heart disease: classification, differential diagnosis, and implications for therapy.

Authors:  S Viskin; B Belhassen
Journal:  Prog Cardiovasc Dis       Date:  1998 Jul-Aug       Impact factor: 8.194

View more
  179 in total

1.  Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia.

Authors:  Hyun Seok Hwang; Can Hasdemir; Derek Laver; Divya Mehra; Kutsal Turhan; Michela Faggioni; Huiyong Yin; Björn C Knollmann
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-01-26

2.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

3.  Detection of genetic variation in KCNQ1 gene by high-resolution melting analysis in a prospective-based series of postmortem negative sudden death: comparison of results obtained in fresh frozen and formalin-fixed paraffin-embedded tissues.

Authors:  Audrey Farrugia; Christine Keyser; Bertrand Ludes
Journal:  Int J Legal Med       Date:  2012-03-09       Impact factor: 2.686

Review 4.  Inherited calcium channelopathies in the pathophysiology of arrhythmias.

Authors:  Luigi Venetucci; Marco Denegri; Carlo Napolitano; Silvia G Priori
Journal:  Nat Rev Cardiol       Date:  2012-06-26       Impact factor: 32.419

5.  Genomic analysis of snub-nosed monkeys (Rhinopithecus) identifies genes and processes related to high-altitude adaptation.

Authors:  Li Yu; Guo-Dong Wang; Jue Ruan; Yong-Bin Chen; Cui-Ping Yang; Xue Cao; Hong Wu; Yan-Hu Liu; Zheng-Lin Du; Xiao-Ping Wang; Jing Yang; Shao-Chen Cheng; Li Zhong; Lu Wang; Xuan Wang; Jing-Yang Hu; Lu Fang; Bing Bai; Kai-Le Wang; Na Yuan; Shi-Fang Wu; Bao-Guo Li; Jin-Guo Zhang; Ye-Qin Yang; Cheng-Lin Zhang; Yong-Cheng Long; Hai-Shu Li; Jing-Yuan Yang; David M Irwin; Oliver A Ryder; Ying Li; Chung-I Wu; Ya-Ping Zhang
Journal:  Nat Genet       Date:  2016-07-11       Impact factor: 38.330

6.  Gene therapy for inherited arrhythmias.

Authors:  Vassilios J Bezzerides; Maksymilian Prondzynski; Lucie Carrier; William T Pu
Journal:  Cardiovasc Res       Date:  2020-07-15       Impact factor: 10.787

7.  Exploring the underlying biology of intrinsic cardiorespiratory fitness through integrative analysis of genomic variants and muscle gene expression profiling.

Authors:  Sujoy Ghosh; Monalisa Hota; Xiaoran Chai; Jencee Kiranya; Palash Ghosh; Zihong He; Jonathan J Ruiz-Ramie; Mark A Sarzynski; Claude Bouchard
Journal:  J Appl Physiol (1985)       Date:  2019-01-03

8.  Anesthetic- and heat-induced sudden death in calsequestrin-1-knockout mice.

Authors:  Marco Dainese; Marco Quarta; Alla D Lyfenko; Cecilia Paolini; Marta Canato; Carlo Reggiani; Robert T Dirksen; Feliciano Protasi
Journal:  FASEB J       Date:  2009-02-23       Impact factor: 5.191

9.  Modulation of cytosolic and intra-sarcoplasmic reticulum calcium waves by calsequestrin in rat cardiac myocytes.

Authors:  Zuzana Kubalova; Inna Györke; Radmila Terentyeva; Serge Viatchenko-Karpinski; Dmitry Terentyev; Simon C Williams; Sandor Györke
Journal:  J Physiol       Date:  2004-10-14       Impact factor: 5.182

10.  Calsequestrin 2 deletion causes sinoatrial node dysfunction and atrial arrhythmias associated with altered sarcoplasmic reticulum calcium cycling and degenerative fibrosis within the mouse atrial pacemaker complex1.

Authors:  Alexey V Glukhov; Anuradha Kalyanasundaram; Qing Lou; Lori T Hage; Brian J Hansen; Andriy E Belevych; Peter J Mohler; Björn C Knollmann; Muthu Periasamy; Sandor Györke; Vadim V Fedorov
Journal:  Eur Heart J       Date:  2013-11-11       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.